Below is your first look at Wagner Moura (The Secret Agent) and Oscar winner Alicia Vikander (The Danish Girl) in upcoming drama The Last Day, also starring Victoria Pedretti (The Haunting of Hill ...

WestEnd Films has acquired international sales rights to “The Last Day,” the feature debut written and directed by artist Rachel Rose, and is releasing an exclusive first picture. The film stars ...

More than two months after First & Last Stop was sold, touching off disputes between its new and former owners, the small bar in New Orleans’ 7th Ward has closed in recent days. But its legacy as a ...

Hip extension during delivery might result in fewer perineal lacerations or anal sphincter injuries, based on data presented at the Society for Maternal-Fetal Medicine (SMFM) 2026 Annual Pregnancy ...

Gen Z, this will smart. The generation born between 1997 and 2010 is the very first generation who did worse in school than the generation before them, according to a top neuroscientist. And ...

With Framber Valdez finally off the market, Zac Gallen is the new top arm available. (Rich Graessle / Icon Sportswire via Getty Images) It’s February, pitchers and catchers report to spring training ...

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

CLEVELAND, Ohio — No two NFL draft classes are the same, and it’s as true in 2026 as any year. On Tuesday, I examined the three position groups that are stronger in this year’s draft than in 2025.

CLEVELAND, Ohio — Every NFL draft class is much different than the year before. As we get deeper into the draft cycle for 2026, I’ll have full position group breakdowns and rankings. But I figured ...

No score yet, be the first to add. The UK duo continues to rail against austerity and oppression on its 13th record. At worst, the album lapses into vague gesturing; at best, it turns diatribes into ...

Still riding the high of last year’s twice-yearly HIV PrEP approval of lenacapavir as Yeztugo, Gilead Sciences is approaching dealmaking from a “position of strength” as a more mature biopharma, ...